No definition available.
Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)
C3_RECTUM_NEUROENDOCRINE_EXALLC
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
124 |
4. Check minimum number of eventsNone |
124 |
5. Include endpointsNone |
124 |
6. Filter based on genotype QC (FinnGen only) |
124 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Neuroendocrine tumor and carcinoma of rectum
- Colorectal neuroendocrine tumor and carcinoma
- Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)
- Colorectal cancer
- Colorectal cancer, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 124 | 72 | 52 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 56.48 | 53.92 | 60.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 113
- Matched controls
- 1130
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8240/3-C20.9
ICD-O-3
Neuroendocrine tumor, NOS, of rectum, NOS
+∞
125.6
96
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
32.7
46.3
64
43
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
33.0
34.0
45
22
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
22.6
21
*
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
+∞
20.4
19
*
UJF32
NOMESCO Finland
Coloscopy
5.5
15.0
56
171
130
Kela drug reimbursment
Malignant tumour
+∞
13.8
13
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.7
12
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
11.7
11
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
11.7
11
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
11.7
11
*
UJF30
NOMESCO Finland
Ileoscopy through colon
7.4
11.4
28
48
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
10.6
10
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
10.6
10.0
19
21
K62.1
ICD-10 Finland
Rectal polyp
26.5
9.1
12
5
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.2
7.8
54
249
H02AB02
ATC
dexamethasone; systemic
27.1
7.7
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
7.4
7
*
JN4BD
NOMESCO Finland
Extensive body CT
7.3
6.6
15
23
A04AA01
ATC
ondansetron; systemic, rectal
19.3
6.4
9
5
WF002
NOMESCO Finland
Radical radiotherapy
+∞
6.3
6
*
8249/3-C20.9
ICD-O-3
Neuroendocrine tumor, grade 2 of rectum, NOS
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
+∞
6.3
6
*
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
6.0
6.1
16
30
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
24
59
4.80
9.49
3.8
1.4
27.52
7.99
ug/l
0.35
19
44
75
396
3.26
9.46
5.8
3.4
35.51
35.81
g/l
0.17
69
367
9
6
16.03
6.00
2.7
1.7
14.51
23.53
ug/l
—
9
6
53
302
2.32
4.85
5.5
2.0
2.37
2.35
mmol/l
0.49
48
246
55
342
2.09
3.87
2.5
2.7
—
—
—
0
0
15
52
3.14
3.61
5.1
7.3
24.47
25.35
mmol/l
0.45
15
52
96
772
2.08
2.94
4.0
4.0
14.48
11.52
mm/h
0.84
89
701
13
48
2.91
2.82
1.8
1.3
—
—
—
0
0
18
80
2.46
2.76
3.8
3.2
—
—
—
0
0
72
540
1.79
2.57
12.0
5.7
4.41
4.18
e9/l
0.32
64
460
43
278
1.84
2.51
2.5
2.6
0.20
0.47
e6/l
1.13
28
201
112
979
2.49
2.43
17.1
10.4
80.69
79.56
ml/min/173m2
0.25
98
769
61
451
1.69
2.18
7.3
5.5
1.22
1.21
mmol/l
0.20
50
390
8
26
3.22
2.05
1.3
1.3
—
—
—
0
0
63
476
1.66
2.03
3.5
4.2
0.00
0.00
estimate
0.00
13
90
5
11
4.69
1.96
1.2
1.4
2.48
339.23
u/ml
—
5
11
114
1026
2.38
1.92
17.1
11.2
17.64
21.50
mg/l
0.87
93
773
31
202
1.71
1.71
2.2
1.7
—
—
—
0
0
61
472
1.58
1.70
2.9
3.1
0.00
0.00
estimate
0.00
13
91
62
486
1.55
1.61
2.8
3.1
0.00
0.00
estimate
0.00
12
85
36
253
1.60
1.48
3.4
3.5
0.00
0.00
estimate
0.00
13
87
29
196
1.63
1.39
1.9
1.7
470.65
449.64
pmol/l
0.21
23
153
53
415
1.48
1.32
3.5
3.5
—
—
—
0
0
5
18
2.85
1.29
2.0
1.1
—
—
—
0
0
8
37
2.24
1.24
3.1
1.5
—
—
—
0
0
47
364
1.47
1.22
3.3
3.2
—
—
—
0
0
6
26
2.37
1.20
1.2
1.2
—
—
—
0
0
0
33
0.00
1.18
0.0
1.6
—
—
—
0
0
0
33
0.00
1.18
0.0
1.5
—
—
—
0
0
50
396
1.44
1.14
3.7
2.2
74.27
77.29
nmol/l
0.32
45
345
40
307
1.45
1.07
4.1
2.7
839.54
1129.46
ng/l
0.42
28
257
9
48
1.94
1.03
1.6
1.3
—
—
—
0
0
0
29
0.00
0.99
0.0
1.3
—
11.99
—
0
9
25
178
1.51
0.96
1.8
1.6
1358.78
1276.82
nmol/l
0.14
18
129
44
352
1.39
0.92
4.1
3.9
2.69
10.46
mg/mmol
2.41
26
219
21
154
1.44
0.71
2.9
2.6
0.77
2.90
e6/l
1.16
11
68
21
155
1.43
0.69
1.5
1.4
—
—
—
0
0
7
44
1.63
0.66
4.0
1.1
—
—
—
0
0
22
168
1.38
0.60
2.8
2.4
0.43
1.07
e6/l
1.55
12
82
0
22
0.00
0.60
0.0
1.3
—
68.18
—
0
22
6
35
1.75
0.58
1.0
1.3
—
—
—
0
0
6
40
1.52
0.52
3.8
1.1
9.63
10.24
g/l
—
6
34
27
220
1.29
0.49
1.4
1.6
1.75
1.14
mg/l
0.40
20
168
48
423
1.22
0.45
2.3
1.8
88.61
96.67
pmol/l
0.72
27
195
14
183
0.74
0.44
1.4
1.3
1.20
11.65
u/ml
—
5
66
5
32
1.59
0.42
1.4
1.2
—
—
—
0
0
5
32
1.59
0.42
1.4
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
8.02
—
0
10
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
0.87
—
0
7
20
161
1.29
0.40
1.4
1.4
—
—
—
0
0
101
965
1.25
0.38
5.3
4.5
1.97
1.93
mu/l
0.11
93
873
108
1042
1.28
0.35
5.1
4.5
6.19
5.99
mmol/l
0.78
98
952
26
222
1.22
0.33
1.3
1.2
0.49
0.80
u/ml
—
7
51
7
52
1.37
0.32
1.9
1.3
—
—
—
0
0
7
54
1.31
0.31
7.4
8.9
0.80
1.54
%
—
7
54
16
130
1.26
0.30
5.9
5.9
—
—
—
0
0
44
399
1.16
0.29
4.4
3.3
21.18
40.83
ng/l
1.39
34
267
24
275
0.84
0.27
4.3
3.5
26.32
25.28
%
0.09
15
126
107
1041
1.20
0.24
4.4
4.6
1.43
1.50
mmol/l
0.99
97
962
61
573
1.13
0.23
2.5
2.8
—
—
—
0
0
5
41
1.23
0.22
2.6
2.5
24.20
25.42
mmol/l
—
5
41
0
11
0.00
0.21
0.0
2.6
—
13.61
—
0
11
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
1.16
—
0
5
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
5.50
—
0
8
72
687
1.11
0.20
3.4
2.9
60.58
46.26
u/l
0.52
67
645
107
1050
1.14
0.14
4.5
4.6
4.52
4.70
mmol/l
1.02
98
973
95
930
1.09
0.11
18.9
12.5
40.63
40.49
%
0.08
60
663
102
1003
1.10
0.10
6.7
5.9
41.28
40.17
mmol/mol
0.50
94
939
10
87
1.16
0.10
5.8
7.5
114.00
122.37
g/l
—
10
87
6
53
1.14
0.09
8.5
9.0
0.72
0.71
%
—
6
53
15
136
1.12
0.09
1.5
1.6
—
—
—
0
0
7
64
1.10
0.08
1.1
2.4
—
—
—
0
0
6
72
0.82
0.08
1.5
2.5
—
—
—
0
0
31
295
1.07
0.07
1.5
1.6
1.43
1.34
mmol/l
0.23
26
250
108
1071
1.07
0.03
5.1
5.2
2.58
2.76
mmol/l
1.26
99
984
101
1003
1.04
0.01
4.1
4.1
1.40
1.29
mmol/l
0.84
92
923
10
97
1.03
0.00
1.3
1.7
—
—
—
0
0
10
95
1.06
0.00
1.3
1.6
—
—
—
0
0
79
786
1.01
0.00
4.9
3.7
15.03
14.75
pmol/l
0.38
73
706
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
805.80
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_RECTUM_NEUROENDOCRINE_EXALLC – Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).